Conclusion Of Non-Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8/130C Paragraph 1 Sgb V For Drugs With The Active Ingredients Fluticasone And Azelastine (R01Ad28) As Part Of A So-Called Open House Model.

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 79948453

  Document Type - Tender Notices

Description - Description Conclusion of non-exclusive discount contracts in accordance with Sections 130a Paragraph 8/130c Paragraph 1 SGB V for drugs with the active ingredients fluticasone and azelastine (R01AD28) within the period from May 1st, 2024 to April 30 th, 2026 with the possibility of concluding the contract at any time (open-house -Model). In the open house procedure, medicines according to the BfArM list according to Section 35 Para. 5a SGB V (childrens medicines) are excluded., local title Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Fluticason und Azelastin (R01AD28) im Rahmen eines sogenannten Open-House-Modells.,

Gt Ref Id - 79948453

Deadline - Feb 28, 2026